The University of Chicago Header Logo

Connection

Rifat Hasina to Carboplatin

Back to Details
This is a "connection" page, showing publications Rifat Hasina has written about Carboplatin.
Rifat Hasina
Connection Strength
0.053
Carboplatin
  1. Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.